CAN THE IRREGULAR ACETYLSALICYLIC ACID (ASA) THERAPY COMBINED WITH INTERVAL TRAINING EXERCISE PROGRAM INCREASE THE CLAUDICATION DISTANCE IN DIABETIC AND NON-DIABETIC PATIENTS WITH FEMORO-POPLITEAL STENOSIS AGE OVER 55

Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović

Abstract


The aim of the study was to estimate the increasing capability of claudications distance in Fontaine's stage IIa of peripheral artery disease by influence of irregular acetylsalicylic acid (ASA) therapy and life style modification, combined with regular physical activity in diabetic and non-diabetic patients age over 55, in order to establish if there were any improvements in claudication distance in the both groups of patients. Method: This study was conducted from beginning of January, 2014 till end of January, 2015 at the Clinic of Vascular Surgery, Clinical Center University of Sarajevo and included 60 patients age over 55 (30 patients who have diabetes mellitus and impellers group consisting of 30 patients who were clinically confirmed not to have diabetes mellitus), male and female, in stadium IIa of peripheral artery disease, with manifestation of mild claudication symptoms. For the testing of statistical significance of differences between the exanimated groups non-parameter and parameter tests were used. The difference at a level of p<0,05 was statistically significant. Results: In all the tested patients, we investigated increasing of claudications distance in diabetic and non-diabetic patients age over 55 years after one year study. Analysis shows the statistically significant influence of antiplatelet therapy (Acetylsalicylic acid) (ASA), combined with physical activity and life style modification on claudications distance over 500 meters in 25 patients without diabetes mellitus in (83% p<0,05), compared to 12 patents with diabetes mellitus (40% p<0,05). Sixteen of non-diabetic patients (53%) were on antiplatelet therapy over 4 years, on permanent treatment, compared to 4 diabetic patients or (3%) (p<0,05). Conclusion: These clinical combined factors appeared to us as being the main strategy of the therapeutic effect on enhancement of claudication distance (Fontaine's stage II) of peripheral artery disease in patients with diabetes mellitus, as well as patients without it.

 

Article visualizations:

Hit counter

DOI

Keywords


peripheral artery disease, claudication distance, diabetes mellitus, physical activity, life style modification

References


Abbott RD, Brand FN, Kannel WB. (1990). Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med. (88),376-381.

Arfvidsson B, Wennmalm A, Gelin J, Dahllof AG, Hallgren B,Lundholm K. (1992). Co-variation between walking ability and circulatory alterations in patients with intermittent claudication. Eur J Vasc Surg. (6), 642- 646.

American Association of Cardiovascular and Pulmonary Rehabilitation-AACPR. (2004). Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. Champaign, IL: Human Kinetics.

Byrne, H., Caulfield, B. & De Vito, G. (2015). Effects of Self-directed Exercise Programmes on Individuals with Type 2 Diabetes Mellitus: A Systematic Review Evaluating Their Effect on HbA1c and Other Metabolic Outcomes. Physical Characteristics, Cardiorespiratory Fitness and Functional Outcomes Sports Med.(26), 1007-1010.

Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. (2006). Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (295), 306-13.

Brun J, Bordenave S, Mercier J, et al. (2008). Cost-sparing effect of twice-weekly targeted endurance training in type 2 diabetics: a one-year controlled randomized trial. Diabetes Metab. 34 (3), 258-265.

Criqui MH, Denenberg JO and al. (1998). The generalized nature of atherosclerosis:how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc. Med. (3), 241-245.

Creager MA, Luscher TF, Cosentino F, et al. (2003). Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.Circulation. (108),1527–1532.

Cobbe S, Taylor R, Prescott R, Lee R,Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R,Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G,McKnight J, O’Brien I, Semple C, Petrie J, Gordon D, Pringle S, Mac Walter R. (2008). The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:1840.

Colwell JA (1997). Aspirin therapy in diabetes (Technical Review). Diabetes Care (20),1767–1771.

Colberg S, Sigal R, Fernhall B, et al. (2010). Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 33(12), 2692–2696.

Cai X, Qiu S, Ju C, Sun Z. (2014). Pedometer-based walking intervention and resting blood pressure in type 2 diabetes: a meta-analysis of randomised controlled studies. Diabetologia (57),434.

Golomb BA, Dang TT, Criqui MH. (2006). Peripheral arterial disease: morbidity and mortality implications. Circulation (114), 688 –699.

Gordon B, Benson A, Bird S, et al. (2009). Resistance training improves metabolic health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 83 (2),157–175.

Hayden M, Pignone M, Phillips C. (2002). Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (136),161–171.

Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, Katzel LI. (2005). Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg. (41), 625– 630.

Jennings AE, Alberga A, Sigal RJ, et al. (2009). The effect of exercise training on resting metabolic rate in type 2 diabetes mellitus. Med Sci Sports Exerc. 41(8),1558–1565.

Karstoft K, Winding K, Knudsen SH, et al. (2013). The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 36 (2),228–236.

Larsen, O.A., and Lassen, NA. (1966). Effect of daily muscular exercise in patients with intermittent claudication. Lancet (2), 1093-1096.

Larose J, Sigal R, Khandwala F, et al. (2012). Comparison of strength development with resistance training and combined exercise training in type 2 diabetes. Scand J Med Sci Sports. 22(4),45–54.

Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N,Jinnouchi H, Sugiyama S, Saito Y. (2008). Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA (3)2134 – 2141.

Plotnikoff R, Eves N, Jung M, et al. (2010). Multicomponent, home-based resistance training for obese adults with type 2 diabetes: a randomized controlled trial. Int J Obes. 34(12), 1733–1741.

Snowling NJ, Hopkins WG. (2006). Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 29(11),2518–2527.

Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. (2007). One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (297), 1197–1206.

Sigal RJ, Kenny GP, Boulé NG, et al. (2007). Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med. 147(6), 357–369.

Thomas RJ, Palumbo PJ, Melton LJ 3rd, et al. (2003). Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970 –1994. Arch Intern Med. (163),445– 451.

Thomas F. Lüscher, MD, Mark A. Creager, MD (2003). Diabetes and Vascular Disease Pathophysiology, Clinical Consequences, and Medical Therapy: Part II. Circulation (108), 1655-1661.

Thomas D, Elliott EJ, Naughton GA. (2009). Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev. (3), 2968.

Weiss, EP., Albert,SG., Reeds,DN; Kress,KS; McDaniel, JL., Klein,S and Villareal, DT. (2016). Effects of matched weight loss from calorie restriction, exercise, or both on cardiovascular disease risk factors. Am J Clin Nutr.27(3),576-586.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Sid Solaković, Mensur Vrcić, Ratko Pavlović, Rubina Alagaić-Alimanović

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2015-2018. European Journal of Physical Education and Sport Science (ISSN 2501 - 1235) is a registered trademark of Open Access Publishing Group. All rights reserved.


This journal is a serial publication uniquely identified by an International Standard Serial Number (ISSN) serial number certificate issued by Romanian National Library (Biblioteca Nationala a Romaniei). All the research works are uniquely identified by a CrossRef DOI digital object identifier supplied by indexing and repository platforms. All authors who send their manuscripts to this journal and whose articles are published on this journal retain full copyright of their articles. All the research works published on this journal are meeting the Open Access Publishing requirements and can be freely accessed, shared, modified, distributed and used in educational, commercial and non-commercial purposes under a Creative Commons Attribution 4.0 International License (CC BY 4.0).